Better Therapeutics' Shares Shoot Higher Following Positive Results From Type 2 Diabetes Study

By: via Benzinga
Better Therapeutics (NASDAQ: BTTX) announced positive results from its pivotal clinical trial for BT-001, prescription digital ...
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.